Brian Kelly is Senior Vice President of Business Development at GeneCentric and is responsible for spearheading the Company’s global business growth strategy, with a focus on diagnostic partnering and biopharmaceutical alliance programs.  A business leader in cancer research and genomic analysis technologies, Mr. Kelly has more than 15 years’ experience in global business and market development, companion diagnostics and biomarker strategies. Prior to joining GeneCentric, he most recently served as Vice President, Global Biopharma and Companion Diagnostics Strategy at Caris Life Sciences and Global Director, Diagnostic Partnering at Thermo Fisher Scientific. Prior to that, he held various clinical market development and commercial roles at Life Technologies, Pacific Biosciences and Affymetrix. Prior to his time in industry, he held research positions at Johns Hopkins University School of Medicine, where he focused on biomarker discovery in oncology. Mr. Kelly holds a bachelor’s degree in biology from Towson University and a master’s degree in biology with a bioinformatics concentration from Johns Hopkins University.